|
|
|
Insider
Information: |
Beer Marc D |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
128,631 |
|
Indirect Shares
|
246,462 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
375,093 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
Percentage
Gain/Loss : |
0.0%
|
60.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Aegerion Pharmaceuticals, Inc. |
AEGR |
Chief Executive Office... |
2014-08-28 |
78,631 |
2014-08-28 |
246,462 |
Premium* |
|
Minerva Neurosciences, Inc. |
NERV |
Director |
2017-03-20 |
50,000 |
2017-03-17 |
0 |
Premium* |
|
Biote Ord Shs Class A |
BTMD |
Director |
2023-01-09 |
0 |
2022-05-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
39 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
|
2010-10-27 |
4 |
B |
$9.50 |
$999,999 |
D/D |
105,263 |
105,263 |
2.81 |
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
|
2010-12-15 |
4 |
B |
$12.33 |
$2,465 |
I/I |
200 |
105,463 |
2.58 |
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
|
2011-04-04 |
4 |
AB |
$16.73 |
$21,916 |
I/I |
1,310 |
111,420 |
0 |
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
|
2011-04-04 |
4 |
AB |
$16.73 |
$77,744 |
D/D |
4,647 |
110,110 |
0 |
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
|
2011-06-01 |
4 |
AB |
$18.69 |
$77,788 |
D/D |
4,162 |
115,582 |
0 |
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
|
2011-06-01 |
4 |
AB |
$18.73 |
$21,914 |
I/I |
1,170 |
116,752 |
0 |
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
|
2011-06-29 |
4 |
S |
$15.50 |
$999,998 |
D/D |
(64,516) |
181,268 |
0 |
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
|
2011-08-01 |
4 |
AB |
$15.74 |
$21,910 |
I/I |
1,392 |
123,082 |
0 |
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
|
2011-08-01 |
4 |
AB |
$15.74 |
$77,724 |
D/D |
4,938 |
121,690 |
0 |
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
|
2011-08-09 |
4 |
AB |
$11.96 |
$98,849 |
D/D |
8,265 |
131,347 |
0 |
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
|
2011-08-09 |
4 |
AB |
$11.91 |
$21,438 |
I/I |
1,800 |
133,147 |
0 |
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
|
2011-09-01 |
4 |
AB |
$14.76 |
$21,904 |
I/I |
1,484 |
7,156 |
0 |
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
|
2011-09-01 |
4 |
AB |
$14.75 |
$77,733 |
D/D |
5,270 |
197,061 |
0 |
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
|
2012-03-22 |
4 |
B |
$13.96 |
$13,964 |
D/D |
1,000 |
198,061 |
2.81 |
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
|
2012-03-29 |
4 |
B |
$13.74 |
$13,735 |
D/D |
1,000 |
199,061 |
2.81 |
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
|
2013-08-15 |
4 |
OE |
$1.54 |
$92,400 |
D/D |
60,000 |
259,061 |
0 |
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
|
2013-08-15 |
4 |
AS |
$87.08 |
$5,312,209 |
D/D |
(60,000) |
199,061 |
0 |
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
|
2013-09-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,335 |
195,726 |
0 |
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
|
2013-10-30 |
4 |
AS |
$84.15 |
$3,511,665 |
D/D |
(40,000) |
195,726 |
0 |
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
|
2013-10-30 |
4 |
OE |
$1.54 |
$61,600 |
D/D |
40,000 |
235,726 |
0 |
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
|
2013-11-05 |
4 |
OE |
$1.54 |
$60,060 |
D/D |
39,000 |
234,726 |
0 |
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
|
2013-12-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,380 |
0 |
0 |
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
|
2013-12-04 |
4 |
OE |
$1.54 |
$6,745 |
D/D |
4,380 |
4,380 |
0 |
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
|
2014-03-26 |
4 |
OE |
$1.54 |
$4,620 |
D/D |
3,000 |
3,000 |
0 |
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
|
2014-05-08 |
4 |
B |
$35.31 |
$1,059,300 |
D/D |
30,000 |
33,000 |
2.81 |
- |
|
39 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|